Top View
- Use of Anti-Glaucoma Drugs to Treat Visual Field Defects Associated with the Use of a Gabaergic Agent
- Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- (12) United States Patent (10) Patent No.: US 6,462,084 B1 Dewevy Et Al
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Dissertatio Final Copy
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Pharmaabkommen A1 E
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Customs Tariff - Schedule Xxi - 1
- Wo 2007/044693 A2
- Tarif Intégré Des Communautés Européennes (TARIC)
- Timothy E Welty Pharmd Ma Fccp Bcps
- (12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
- Harmonized Tariff Schedule of the United States (2006) (Rev
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- LOCALISATION and MODULATION of Gabab and 5-HT3
- Sem Título-6
- Gabaergic Dysfunction in Mood Disorders
- M Áster En Biotecnología Y Biom Edicina
- Semicarbazone – a Versatile Therapeutic Pharmacophore for Fragment Based Anticonvulsant Drug Design
- Reviews Essential Tremor: What We Can Learn from Current Pharmacotherapy
- Neurological Disease
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Behavioural Neurology of Anti-Epileptic Drugs
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- An Update on Prodrugs from Natural Products
- Design, Synthesis, and Anticonvulsant Evaluation of 4-GABA-3- Nitrocoumarines, 1-Thiocoumarines, Quinolone-2-Ones, and Their Derivatives
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- WO 2016/179252 Al 10 November 2016 (10.11.2016) P O P C T
- Gamma-Aminobutyric Acid Was First Synthesized in 1883, [Citation Needed ] and Was First Known Only As a Plant and Microbe Metabolic Product
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- Phase 1B Pharmaco-MRS Pilot Study of Clavulanic Acid After Repeated Administration
- Calibration of in Vitro MDR1 Substrate and Inhibition Assays As a Basis to Support the Prediction of Clinically Relevant Interactions in Vivo
- Gamma-Aminobutyric Acid 1 Gamma-Aminobutyric Acid
- Redox Systems for Brain-Targeted Drug Delivery
- Medications Associated with Geriatric Syndrome (MAGS) and Their Prevalence in Older Hospitalized Adults Discharged to Skilled Nursing Facilities
- Schedule Clxxiii - European Union
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- Pharmacological Studies on Gaba-Transaminase Inhibitors